Facense

Company Overview

Snapshot

Founded in May 2015 by Gil Thieberger, Ori Tzvieli, Tal Thieberger-Navon, and Arie Tzvieli, Facense operates with 1–10 employees. The company secured two funding rounds, focusing on its smartglasses technology. Facense ceased operations in June 2026.

Business overview

Facense develops smartglasses equipped with small sensors designed for continuous and unobtrusive measurement of vital signs and emotional responses. This technology aims to detect and predict various medical conditions, including hypertension, stroke, congestive heart failure, asthma, chronic obstructive pulmonary disease, migraines, and early COVID-19 symptomatic behavior. The company's focus on continuous physiological monitoring enhances telehealth applications and provides diverse medical uses. Facense operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Patient Remote Monitoring, serving markets such as the United States, Southeast Asia, and Europe.

Company Intelligence Q&A

What is Facense's primary product?

Facense develops smartglasses with integrated sensors that continuously measure vital signs and emotional responses, enabling the detection and prediction of various medical conditions.

When was Facense founded?

Facense was founded in May 2015.

Who are the founders of Facense?

The founders of Facense are Gil Thieberger, Ori Tzvieli, Tal Thieberger-Navon, and Arie Tzvieli.

What is the current operational status of Facense?

Facense ceased to operate in June 2026.

What markets does Facense target with its technology?

Facense targets geomarkets including the United States, Southeast Asia, and Europe with its smartglasses technology.